Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Clin Gastroenterol Hepatol. 2014 Mar;12(3):382-93.e1: quiz e22. doi: 10.1016/j.cgh.2013.08.023. Epub 2013 Aug 24.
BACKGROUND & AIMS: Inflammatory bowel disease (IBD) is associated with an increased risk of venous thromboembolic disease. However, it is unclear whether IBD modifies the risk of arterial thromboembolic events, including cerebrovascular accidents (CVA) and ischemic heart disease (IHD).
We performed a systematic review and meta-analysis of cohort and case-control studies that reported incident cases of CVA and/or IHD in patients with IBD and a non-IBD control population (or compared with a standardized population). We calculated pooled odds ratios (ORs) with 95% confidence intervals (CIs).
We analyzed data from 9 studies (2424 CVA events in 5 studies, 6478 IHD events in 6 studies). IBD was associated with a modest increase in the risk of CVA (5 studies; OR, 1.18; 95% CI, 1.09-1.27), especially among women (4 studies; OR, 1.28; 95% CI, 1.17-1.41) compared with men (OR, 1.11; 95% CI, 0.98-1.25), and in young patients (<40-50 y old). The increase in risk was observed for patients with Crohn's disease and in those with ulcerative colitis. IBD also was associated with a 19% increase in the risk of IHD (6 studies; OR, 1.19; 95% CI, 1.08-1.31), both in patients with Crohn's disease and ulcerative colitis. This risk increase was seen primarily in women (4 studies; OR, 1.26; 95% CI, 1.18-1.35) compared with men (OR, 1.05; 95% CI, 0.92-1.21), in young and old patients. IBD was not associated with an increased risk of peripheral arterial thromboembolic events. Considerable heterogeneity was observed in the overall analysis.
IBD is associated with a modest increase in the risk of cardiovascular morbidity (from CVA and IHD)-particularly in women. These patients should be counseled routinely on aggressive risk factor modification.
炎症性肠病(IBD)与静脉血栓栓塞性疾病的风险增加相关。然而,IBD 是否会改变动脉血栓栓塞事件(包括中风和缺血性心脏病)的风险尚不清楚。
我们对报道了 IBD 患者和非 IBD 对照人群(或与标准化人群相比)中中风和/或缺血性心脏病的发生率病例的队列和病例对照研究进行了系统评价和荟萃分析。我们计算了合并的比值比(OR)及其 95%置信区间(CI)。
我们分析了 9 项研究的数据(5 项研究中有 2424 例中风事件,6 项研究中有 6478 例缺血性心脏病事件)。IBD 与中风风险增加(5 项研究;OR,1.18;95%CI,1.09-1.27)相关,尤其是在女性(4 项研究;OR,1.28;95%CI,1.17-1.41)中与男性(OR,1.11;95%CI,0.98-1.25)相比,且在年轻患者(<40-50 岁)中也是如此。这种风险增加见于克罗恩病和溃疡性结肠炎患者。IBD 也与缺血性心脏病风险增加 19%(6 项研究;OR,1.19;95%CI,1.08-1.31)相关,在克罗恩病和溃疡性结肠炎患者中均如此。这种风险增加主要见于女性(4 项研究;OR,1.26;95%CI,1.18-1.35)与男性(OR,1.05;95%CI,0.92-1.21)相比,在年轻和老年患者中也是如此。IBD 与外周动脉血栓栓塞事件的风险增加无关。在总体分析中观察到了相当大的异质性。
IBD 与心血管发病率(中风和缺血性心脏病)适度增加相关-特别是在女性中。这些患者应常规接受积极的危险因素改变的咨询。